Amlodipine Besylate And Olmesartran Medoxomil Tablet, Film Coated
Product Images NDC 62332-213

7 FDA label images from Alembic Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Olmesartran Medoxomil (NDC 62332-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amloolmi Fig1)

Figure 1 (Amloolmi Fig1)
This image contains four line graphs depicting the probability of achieving specific systolic and diastolic blood pressure targets at Week 8 with LOCF. The graphs compare placebo, Amlodipine besylate 10 mg, and a combination of Amlodipine besylate and Olmesartran medoxomil 10 mg/40 mg tablets, showing probabilities versus baseline systolic and diastolic blood pressure values.*
FDA Label Image

Amlodipine Besylate (Amloolmi Amlo)

Amlodipine Besylate (Amloolmi Amlo)
Chemical structure of Amlodipine besylate, showing its molecular configuration with functional groups and the besylate moiety attached.*
FDA Label Image

Olmesartan Medoxomil (Amloolmi Olmi)

Olmesartan Medoxomil (Amloolmi Olmi)
Chemical structure diagram of Amlodipine besylate and Olmesartran medoxomil showing molecular bonds and atomic groups.*
FDA Label Image

30 Tablets (Amloolmi 5 20 mg)

30 Tablets (Amloolmi 5 20 mg)
Label for Amlodipine and Olmesartan Medoxomil Tablets, USP, strength 5 mg/20 mg, film-coated tablets. The package contains 30 tablets. The label includes storage instructions and manufacturer information, listing Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA. The product is prescription-only with NDC 62332-212-30.*
FDA Label Image

30 Tablets (Amloolmi 5 40 mg)

30 Tablets (Amloolmi 5 40 mg)
Label of Amlodipine and Olmesartan Medoxomil tablets, USP containing 5 mg/40 mg film-coated tablets. The package is labeled for 30 tablets and is marked Rx only. The label shows manufacturing by Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA. It includes storage instructions and a barcode with an NDC number 62332-213-30.*
FDA Label Image

30 Tablets (Amloolmi 10 20 mg)

30 Tablets (Amloolmi 10 20 mg)
Label for Amlodipine and Olmesartan Medoxomil Tablets, USP 10 mg/20 mg, oral film-coated tablets. The label shows the manufacturer's name as Alembic Pharmaceuticals Limited (India) and Alembic Pharmaceuticals, Inc. (USA). The label includes dosage strength, quantity of 30 tablets, storage instructions at 25°C, and regulatory details including NDC 62332-214-30.*
FDA Label Image

30 Tablets (Amloolmi 10 40 mg)

30 Tablets (Amloolmi 10 40 mg)
A packaging label for Amlodipine and Olmesartan Medoxomil Tablets, USP, with a strength of 10 mg/40 mg. The label states the product is prescription only, contains 30 tablets, and is manufactured by Alembic Pharmaceuticals Inc. Storage instructions and manufacturer details for Alembic Pharmaceuticals Limited in India are included, along with a barcode and NDC 62332-215-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.